Abstract:OBJECTIVE: To investigate the effectiveness of osteoking, a Traditional Chinese Medicine originating from Yi nationality, against osteoporosis (OP) and osteoporotic fracture (OPF), and to elucidate its mechanism of action. METHODS: An osteoporotic fracture rat model was established; animals were divided into three treatment groups: parathyroid hormone, osteoking and 0.9%NaCI. After 4, 8 and 12 weeks of treatment, serum and bone tissues were collected. Enzyme-linked immuno sorbent assay, x-ray, histopathological evaluation and proteomics were used. Proteomics and GO annotation were performed based on identified peptides. The relative network was obtained from the STRING database and verified by polymerase chain reaction and Western blotting. RESULTS: After osteoking treatment, the bone mineral density (BMD) increased with time in the osteoking group. At week 12, the BMD and bone mineral salt content of the osteoking group were 4.5% and 20.6% higher than those of the negative control group, respectively. Furthermore, the body weight followed the order of positive control group > osteoking group > negative control group, with significant differences among the groups (P < 0.05). Micro-CT analysis of femur sections revealed that the bone surface/volume ratio was significantly higher in the osteoking group than that in the negative control group. X-ray images demonstrated that the osteoking group showed clear callus. Moreover, high-voltage micro-CT demonstrated a massive cortical bone accumulation in the osteoking group. The gray values of callus in the osteoking group were higher than those in the negative group. From week 4 to 12, the serum bone alkaline phosphatase level increased by 49.6% in the osteoking group and the serum propeptide of type I procollagen level decreased by 80.6%. Alizarin red staining demonstrated that the calcium deposition in the osteoking group was higher than that in the negative control group. Notably, the expression of Mgp, a key osteogenesis inhibitor, was lower in the osteoking group compared with the negative control group. Moreover, Sparc, bone morphogenetic protein-2 and Bglap expression was higher in the osteoking group through activation of the transforming growth factor-receptor activator of nuclear factor kappa B Ligand pathway. CONCLUSION: Osteoking treatment increased bone quality and promoted calcium deposition. The results suggest that osteoking inhibits Mgp through the TGF-beta/RANKL pathway to improve OP/OPF. (C) 2020 JTCM. All rights reserved.

Omentin‑1 Induces Osteoblast Viability and Differentiation Via the TGF‑β/Smad Signaling Pathway in Osteoporosis.

Alpinetin Inhibits RANKL-Induced Osteoclastogenesis and Ovariectomy-Induced Bone Loss by Modulating NFATc1 Transcription and Lysosomal Function

Omentin-1 Attenuates Arterial Calcification and Bone Loss in Osteoprotegerin-Deficient Mice by Inhibition of RANKL Expression.

Omentin-1 Exerts Bone-Sparing Effect in Ovariectomized Mice

Omentin-1 Stimulates Human Osteoblast Proliferation through PI3K/Akt Signal Pathway

Omentin-1 prevents inflammation-induced osteoporosis by downregulating the pro-inflammatory cytokines

Administration of SB239063 Ameliorates Ovariectomy-Induced Bone Loss Via Suppressing Osteoclastogenesis in Mice

Omentin Inhibits Osteoblastic Differentiation of Calcifying Vascular Smooth Muscle Cells Through the PI3K/Akt Pathway

Omentin-1: a newly discovered warrior against metabolic related diseases

Osteoking downregulates Mgp in an osteoporotic fracture rat model.

Osthole Inhibits Osteoclast Formation and Enhances Bone Mass of Bone Marrow Mesenchymal Stem cells by Activating β-catenin-OPG Signaling Pathway

Omentin-1 protects against bleomycin-induced acute lung injury

Omentin-1 drives cardiomyocyte cell cycle arrest and metabolic maturation by interacting with BMP7

Omentin-1 attenuates lipopolysaccharide-induced inflammation and osteogenic differentiation in periodontal ligament stem cells and reduces M1 macrophages polarization through repressing endoplasmic reticulum stress

Adipose Tissue-Derived Omentin-1 Attenuates Arterial Calcification Via AMPK/Akt Signaling Pathway.

TGF-β Induces Wnt10b in Osteoclasts From Female Mice to Enhance Coupling to Osteoblasts

Osthole Enhances the Bone Mass of Senile Osteoporosis and Stimulates the Expression of Osteoprotegerin by Activating Β-Catenin Signaling

Endothelial Zeb1 Promotes Angiogenesis-Dependent Bone Formation And Reverses Osteoporosis

Effect of adiponectin on the expression of osteoprotegerin and receptor activator of nuclear factor-kappa B ligand in osteoblasts

Tenuigenin promotes the osteogenic differentiation of bone mesenchymal stem cells in vitro and in vivo